We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Teva Pharmaceutical Industries has filed a patent infringement suit against Mylan Pharmaceuticals and Natco Pharma to stop sales of a proposed generic version of the multiple sclerosis (MS) drug Copaxone.